21.01.2011 • NewsDSM

DSM, Russia's KuibyshevAzot Enter Automotive Plastics JVs

Dutch DSM said on Thursday it would take a majority stake in two engineering plastics joint ventures in Russia with KuibyshevAzot to tap into an expected recovery in the Russian car market.

Russia's annual car sales are expected to return to pre-crisis levels of 2.9 million units in 2012, on the back of the government's car scrappage scheme and pent-up demand.

Russia had been on track to overtake Germany as Europe's biggest car market before the global economic crisis sparked a collapse in sales in 2009.

DSM and KuibyshevAzot (KA), a Russian chemicals company, said on Thursday they would set up a marketing and sales joint venture in Russia and other countries in the region, with DSM taking a 51% stake.

DSM added it will buy 80% of an engineering plastics plant located at a KA manufacturing site, but did not disclose the financial details or the capacity of the plant. Engineering plastics are used in the auto industry.

The deal, under which DSM will receive royalty income over a period of 15 years, is subject to regulatory approval. The acquisition of the KA plant is expected to be completed in the first quarter.

Company

Royal DSM N.V.


6401 JH Heerlen

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.